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preceded by a thorough science based review of suitability 
and safety by an independent authority. Food safety events 
should be managed on an international basis. Global collab-
oration of food producers, food-safety authorities, paediatri-
cians and scientists is needed to efficiently exchange infor-
mation and to best protect public health. 
 Copyright © 2012 S. Karger AG, Basel 
 The interest of pediatricians, other health care profes-
sionals, and the public in infant nutrition products is of-
ten focused on possible functional effects, such as poten-
tial risk reduction of allergic disorders or the potential 
benefits for child development or long-term health  [1, 2] . 
In contrast, pediatricians and other health care profes-
sionals often assume quality and safety as a matter of 
course and do not devote the same level of attention to 
these aspects. 
 However, quality and safety issues are of key impor-
tance for infant feeding and child health. Suitability and 
safety are fundamental regulatory requirements for al-
lowing the marketing of infant food products  [3] . These 
aspects are important because infants carry particularly 
high risks for untoward effects of unbalanced diets or of 
harmful food components. Why? Because they grow rap-
idly and have high nutrient needs, and because during the 
first months after birth usually one sole milk source must 
meet all the dietary requirements. Further, immature and 
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 Abstract 
 Quality and safety aspects of infant nutrition are of key im-
portance for child health, but oftentimes they do not get 
much attention by health care professionals whose interest 
tends to focus on functional benefits of early nutrition. Un-
balanced diets and harmful food components induce par-
ticularly high risks for untoward effects in infants because of 
their rapid growth, high nutrient needs, and their typical de-
pendence on only one or few foods during the first months 
of life. The concepts, standards and practices that relate to 
infant food quality and safety were discussed at a scientific 
workshop organized by the Child Health Foundation and the 
Early Nutrition Academy jointly with the European Society 
for Paediatric Gastroenterology, Hepatology and Nutrition, 
and a summary is provided here. The participants reviewed 
past and current issues on quality and safety, the role of dif-
ferent stakeholders, and recommendations to avert future 
issues. It was concluded that a high level of quality and safe-
ty is currently achieved, but this is no reason for complacen-
cy. The food industry carries the primary responsibility for 
the safety and suitability of their products, including the 
quality of composition, raw materials and production pro-
cesses. Introduction of new or modified products should be 
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rapidly developing infants have a high susceptibility to 
harmful effects from many exposures.
 Breast-feeding is regarded as the optimal form of nu-
trition for human infants because of its numerous health 
advantages, including, for example, prevention of infec-
tious diseases, promotion of neurodevelopment, and re-
duced risk of later obesity, diabetes, and hypertension 
 [4–6] . Despite these recommendations, the vast majority 
of infants worldwide receive some infant formula at some 
time during their first year of life, whether as their sole 
source of nutrition or in combination with human milk, 
or homemade or commercial complementary foods. 
Hence, the concepts, standards, and practices that relate 
to the quality and safety of food products for infants are 
of great public health importance.
 A workshop was held in Sorrento, Italy, in May 2011, 
on behalf of the charitable Child Health Foundation, Mu-
nich (www.kindergesundheit.de) and the Early Nutrition 
Academy (www.early-nutrition.org), in collaboration 
with the European Society for Pediatric Gastroenterolo-
gy, Hepatology and Nutrition (www.espghan.org) to re-
view and discuss some of the key questions in this area. 
They specifically addressed the following questions:
 (1) What lessons have we learned from past issues of qual-
ity and safety?  
 (2) What do we agree are the current issues for quality and 
safety?  
 (3) What do we predict might be future issues for quality 
and safety and why?  
 (4) Which stakeholders should worry about current and 
future quality and safety issues (manufacturers, gov-
ernment, health professionals, others)? Why are they 
issues for them?  
 (5) What recommendations do we agree for these stake-
holder groups to improve concerning any current is-
sues and to avert any predicted future issues? 
 This report summarizes some general issues addressed 
by the workshop. It is complemented by a series of reports 
published in this issue of the journal which provide sum-
maries and key conclusions of presentations held at the 
workshop.
 Safety Issues: Nutrient Contents 
 Standards and regulations for infant formula and oth-
er infant foods aim at ensuring high levels of safety and 
are much more rigorous than regulations for other food 
products  [3, 7–9] . In fact, it was a serious safety issue that 
led to the adoption of the US Infant Formula Act in 1980. 
The issue was the change in the formulation of two soy 
infant formulae which were introduced in 1978 by a major 
infant formula manufacturer in the USA, with a marked 
reduction in the sodium chloride content. These chloride 
deficient formulations induced hypochloremic metabolic 
alkalosis and growth faltering in the babies who received 
them, and they were later also found to be associated with 
adverse long-term effects on developmental outcomes and 
with behavioral problems  [10–13] . The United States Con-
gress reviewed the matter and determined that protection 
of infants fed infant formulae needed to be improved by 
greater regulatory control over infant formula, which led 
to the US Infant Formula Act of 1980 (Pub. L 96–359). 
This act first established minimum nutrient requirements 
for infant formulae, defined adulteration and quality con-
trol procedures, and specified inspection requirements as 
well as recall procedures  [9] .
 The establishment of this and further national, region-
al, and global standards and regulations on infant formu-
lae and baby foods has contributed to the very high level 
of safety of such products that exists today. Compared to 
the enormous number of infants fed such products on a 
daily basis, only a very small number of adverse events 
has become known.
 However, in spite of established standards and regula-
tions, the occurrence of nutrient deficiency due to com-
positional errors can still occur. In 2003, a thiamine defi-
cient soy protein-based infant formula led to severe thia-
mine deficiency in recipient infants with lactic acidosis, 
encephalopathy, cardiomyopathy, and deaths  [14, 15] , 
along with long-term neurologic problems in surviving 
children  [16–18] . This tragedy apparently resulted from 
an error of the manufacturer in designing the nutrient 
composition of the formula  [19, 20] , and it calls for the ap-
plication of even more stringent quality control measures.
 Not only nutrient deficiency, but also too high nutrient 
intakes may cause adverse effects. An excessive supply of 
dietary components, and the supply of unnecessary com-
ponents, can put a burden on the infant’s metabolic and 
other functions. Dietary components that are not utilized 
or stored by the body must be excreted as such or in the 
form of metabolites, in most cases as solutes with the urine. 
However, water available to form urine is limited, and in-
fants particularly during the first months of life have a lim-
ited ability to concentrate urine. Therefore, the need to ex-
crete any additional solutes can reduce the margin of safe-
ty, particularly if the infant is stressed by fever or diarrhea.
 An impressive example of untoward effects of a too 
high nutrient intake is the observation that an additional 
daily iron intake of 1 mg/kg from 6 to 9 months of age 
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induces significantly impaired length growth in iron suf-
ficient infants  [21, 22] . Therefore, it is important to define 
not only adequate minimum but also maximum ingredi-
ent contents in infant food products  [8] .
 Adulteration 
 Probably the largest infant food safety problem ever 
occurred in 2008 in China: infant formula was produced 
from milk to which melamine had been added to sham a 
higher protein content, which caused urolithiasis and re-
lated damage in a large number of infants  [23–27] . It is 
estimated that more than 300,000 infants were exposed to 
such adulterated formula, with tens of thousands of hos-
pitalizations and 6 reported deaths  [27, 28] . This inten-
tional milk contamination with melamine had interna-
tional implications due to the global distribution of these 
products and delayed reporting. This led to exposure to 
melamine-contaminated products originating from Chi-
na, or to products containing contaminated ingredients 
from China, not only across Asia but also in Africa, Aus-
tralia/New Zealand, Europe, and North America  [25, 28] .
 Another case of adulteration became known in 2011, 
when a major incident of phthalate-contaminated food-
stuffs occurred in Taiwan. The toxic compounds di-(2-
ethylhexyl)phthalate and diisononyl phthalate were de-
liberately added to foodstuffs to substitute for an emulsi-
fier, including foods that were consumed by infants  [29] . 
Again, phthalate-contaminated products were exported 
to and found in several other countries. The supply of 
phthalate to infants is of concern, since phthalate expo-
sure in early life has been associated with endocrine dis-
rupting effects, impaired growth, mental and motor de-
velopment, and increased risk for heart defects  [30–33] .
 Microorganisms and Their Toxins 
 Food products, including powdered infant formulae, 
are not sterile but may contain viable microorganisms, 
including pathogens such as  Salmonella enterica ,  Salmo-
nella typhi ,  Shigella dysenteriae  or  Cronobacter sakazakii 
 [34–36] that can cause serious infections in infants. In 
recent years, there have been numerous recurrences of 
invasive infections with  Cronobacter sakazakii  that led to 
bacteremia, necrotizing enterocolitis and meningitis – 
predominantly in premature infants – which were related 
to the consumption of infant formula reconstituted from 
powder contaminated with these bacteria  [37–40] . Oc-
currence of invasive infections occurred after prolonged 
storage of reconstituted formula at warm temperatures 
which can lead to a marked increase in bacterial numbers 
and hence reach an infective dose  [41, 42] . Reij et al.  [43] 
 recently estimated the burden of disease of  Cronobacter 
infections in infants to the Dutch population as 19–24 
disability-adjusted life years (DALYs) per year, of which 
95% are due to meningitis. Based on these estimates, 
Cronobacter infections represent 0.5–2.4% of the total es-
timated burden of foodborne infections and intoxica-
tions and would be responsible for 0.5–0.7% of the men-
ingitis burden to the entire Dutch population. Due to 
such concerns, numerous product recalls of powdered in-
fant formulae batches in which  C. sakazakii had been de-
tected, even at low numbers, have occurred. Some experts 
and authorities have also recommended the preparation 
of all infant formulae with water heated to at least 70  °  C 
to inactivate live bacteria. However, it is unclear whether 
this measure reduces infection risks in newborn, term or 
older infants if prolonged formula storage is avoided. At 
the same time, preparation of infant formula with water 
heated to at least 70  °  C will definitely reduce its nutrition-
al quality  [42, 44, 45] and increases the risk of scalding 
injuries from hot water which frequently occur in infants 
 [46] .
 Safety concerns due to microbial contamination are 
not limited to commercial infant foods. Human breast 
milk and homemade complementary foods may bear sig-
nificant contamination with microorganisms and afla-
toxins, particularly in low-income countries  [47–50] , 
whereas commercial baby foods generally contain very 
low amounts of mycotoxins  [51] . Aflatoxin contamina-
tion of foods contributes a significant public health bur-
den in low-income countries due to their carcinogenicity 
and their growth-impairing effects in children  [52] .
 Contaminants and Residues 
 European legislation stipulates the absence of appre-
ciable contaminant levels in foodstuffs for particular nu-
tritional uses intended for infants and young children, 
which includes infant and follow-on formulae and com-
mercial baby foods, with a very low common limit for 
pesticide residues of 0.01 mg/kg (1 ppm) considered to be 
close to the minimum detectable level  [3] . Nonetheless, a 
minimal residual risk cannot be excluded with absolute 
certainty. For example, concern has been raised regard-
ing the exposure to endocrine disruptors through infant 
foods with respect to potential impact on health, given 
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that infants are thought to be more sensitive to hormonal 
impacts of environmental chemicals than adults  [53] .
 Exposure to other contaminants must also be consid-
ered. For example, in parenterally fed premature infants, 
aluminum exposure from glassware was related to im-
paired developmental outcomes. In a randomized clini-
cal trial, premature infants exposed for  1 10 days to stan-
dard parenteral feeding solutions had more impaired 
neurologic development at 18 months than infants ran-
domized to solutions especially sourced for low alumini-
um content  [54] . Therefore, it is now recommended to 
limit aluminium exposure of parenterally fed children as 
much as possible, and to avoid the repeated use of calcium 
gluconate in small-volume glass containers for treatment 
in children up to 18 years of age  [54] . Significant alumin-
ium contents have also been found in some infant formu-
lae, including soy protein-based formulae as well as lac-
tose-free, hypoallergenic, and preterm formulae, but it 
remains unknown whether the enteral exposure to these 
aluminium concentrations has any relevant biological ef-
fects  [55, 56] . A recent model calculation estimated that 
the total body burden of aluminium in healthy infants 
from both vaccines and diet throughout the first year of 
life is significantly lower than the corresponding safe 
body burden of aluminium, using the regulatory mini-
mum risk level  [57] .
 Among the contaminants that can be newly formed 
during the production of foodstuffs are furan and acryl-
amide. Furan is formed under heat exposure from carbo-
hydrates, ascorbic acid, and polyunsaturated fatty acids. 
Furan has been classified as a ‘possible human carcino-
gen’ and is found in low concentrations in some baby 
foods  [58, 59] . Acrylamide, another possible carcinogen, 
is formed during heating of starchy foods for longer peri-
ods of time and has been detected in low amounts in in-
fant formulae and commercial baby foods  [60] . Much 
higher concentrations of acrylamide can occur in home-
made and general foods fed to infants and young chil-
dren, who reach much higher exposures than all other 
parts of the population  [61, 62] . The European Commis-
sion has recommended to monitor the content of major 
newly formed contaminants, such as acrylamide and fu-
ran, in food products and to aim at achieving low levels 
whenever possible  [63, 64] . Industry has taken active 
measures to minimize contents of newly formed contam-
inants in food products  [65, 66] .
 In addition to components derived from the raw mate-
rial and the production process of foodstuffs, also pack-
aging materials and feeding devices can add to the expo-
sure to substances with potentially untoward effects. For 
example, the migration of significant amounts of poten-
tially toxic components from baby bottles into feeds, such 
as bisphenol A (BPA), plasticizers, esters, and certain an-
tioxidants, must be avoided  [67–69] . 
 Conclusions 
 The experts attending this workshop emphasized that, 
currently, a very high level of quality and safety in infant 
feeding is achieved but agreed that this was no reason for 
complacency. The public expectation is that infant feed-
ing should be absolutely safe, that is 100% free of any risks 
for or any harm to the baby. However, from a scientific 
perspective an absolute safety cannot be guaranteed, but 
rather one aims at the highest level of risk reduction that 
is achievable, i.e. the approach has to be one of relative 
safety, which is not always an easy concept to explain to 
the public.
 There was agreement that the introduction of new or 
modified infant food products should be preceded by a 
systematic review of the available evidence, and usually 
preclinical safety assessment followed by evaluation in 
clinical trials according to current scientific standards 
 [70–73] . Consumers and health care professionals expect 
any new ingredient to be thoroughly tested by scrupu-
lously conducted clinical trials which usually assess 
growth, monitor adverse events, and are evaluated by the 
appropriate regulatory body (EFSA for Europe, GRAS 
status and FDA in the USA)  [74, 75] . The pediatric par-
ticipants at the workshop agreed that the introduction of 
new or modified infant food products into the market 
should require an evaluation of their suitability and safe-
ty by an independent authority, which at present is the 
case, for example, in the USA and Australia but not in 
Europe  [74, 75] .
 The food industry is expected to use safe and suitable 
ingredients that meet the highest purity standards and 
assume that these are present in the infant foods at levels 
(lower and upper) stipulated by legislation. Control of in-
gredient quality and of good manufacturing practice ap-
pears to be of great importance for ensuring product safe-
ty, and weaknesses regarding these aspects appear to have 
contributed to the frequent recalls and warnings on in-
fant food products that appeared in recent years. Such 
incidents appear to happen mostly because of violation of 
good production process standards and/or insufficient 
control of the supplied ingredients. Moreover, there may 
be considerable pressure to reduce cost of production, 
which could create incentives to compromise on quality. 
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Human error is often found to be the primary cause, but 
the impact of human error can best be minimized by em-
ploying the highest possible quality and safety standards, 
which the industry is encouraged to implement.
 The scientific experts attending this workshop agreed 
that managing food safety events should be done on an 
international basis. Global collaboration of food produc-
ers, food safety authorities, and scientists is needed to ef-
ficiently exchange information and to best protect public 
health.
 Acknowledgements 
 Partial financial support from the Commission of the Euro-
pean Community, specific RTD Programme ‘Quality of Life and 
Management of Living Resources’, within the 7th Framework 
Programme, research grant No. FP7-KBBE-2011-5-289346 (EAR-
LY NUTRITION) is gratefully acknowledged. This paper does 
not necessarily reflect the views of the Commission and in no way 
anticipates the future policy in this area. We thank Abbott Nutri-
tion, Danone Research, Dairy Goat Cooperative, DSM Nutrition-
al Products, Hipp GmbH, Mead Johnson Nutritionals and United 
Pharmaceuticals for additional support through unrestricted 
 educational grants.
 
 References 
 1 Koletzko B, Aggett PJ, Bindels JG, et al: 
Growth, development and differentiation: a 
functional food science approach. Br J Nutr 
1998; 80(suppl 1):S5–S45. 
 2 Szajewska H, Makrides M: Is early nutrition 
related to short-term health and long-term 
outcome? Ann Nutr Metab 2011; 58(suppl 
1):38–48. 
 3 European-Commission: Commission Di-
rective 2006/141/EC of 22 December 2006 on 
infant formulae and follow-on formulae and 
amending Directive 1999/21/EC. Official 
Journal of the European Union 2006;L 401/1 
20.12.2006. 
 4 Agostoni C, Braegger C, Decsi T, et al: Breast-
feeding: a commentary by the ESPGHAN 
Committee on Nutrition. J Pediatr Gastro-
enterol Nutr 2009; 49: 112–125. 
 5 Koletzko B, von Kries R, Monasterolo RC, et 
al: Infant feeding and later obesity risk. Adv 
Exp Med Biol 2009; 646: 15–29. 
 6 Rebhan B, Kohlhuber M, Schwegler U, 
Fromme H, Abou-Dakn M, Koletzko BV: 
Breastfeeding duration and exclusivity asso-
ciated with infants’ health and growth: data 
from a prospective cohort study in Bavaria, 
Germany. Acta Paediatr 2009; 98: 974–980. 
 7 Zlotkin S, Siekmann J, Lartey A, Yang Z: The 
role of the Codex Alimentarius process in 
support of new products to enhance the nu-
tritional health of infants and young chil-
dren. Food Nutr Bull 2010; 31:S128–S133. 
 8 Koletzko B, Baker S, Cleghorn G, et al: Glob-
al standard for the composition of infant for-
mula: recommendations of an ESPGHAN 
coordinated international expert group. J 
Pediatr Gastroenterol Nutr 2005;  41: 584–
599. 
 9 Newberry RE: The Infant Formula Act of 
1980. J Assoc Off Anal Chem 1982; 65: 1472–
1473. 
 10 Kaleita TA: Neurologic/behavioral syn-
drome associated with ingestion of chloride-
deficient infant formula. Pediatrics 1986; 78: 
 714–715. 
 11 Malloy MH, Graubard B, Moss H, et al: Hy-
pochloremic metabolic alkalosis from inges-
tion of a chloride-deficient infant formula: 
outcome 9 and 10 years later. Pediatrics 1991; 
 87: 811–822. 
 12 Silver LB, Levinson RB, Laskin CR, Pilot LJ: 
Learning disabilities as a probable conse-
quence of using chloride-deficient infant 
formula. J Pediatr 1989; 115: 97–99. 
 13 Willoughby A, Graubard BI, Hocker A, et al: 
Population-based study of the developmen-
tal outcome of children exposed to chloride-
deficient infant formula. Pediatrics 1990; 85: 
 485–490. 
 14 Fattal-Valevski A, Kesler A, Sela BA, et al: 
Outbreak of life-threatening thiamine defi-
ciency in infants in Israel caused by a defec-
tive soy-based formula. Pediatrics 2005; 
 115:e233–e238. 
 15 Kornreich L, Bron-Harlev E, Hoffmann C, et 
al: Thiamine deficiency in infants: MR find-
ings in the brain. AJNR Am J Neuroradiol 
2005; 26: 1668–1674. 
 16 Lanska DJ, Fatal-Valevski A: Epilepsy in chil-
dren with infantile thiamine deficiency. Neu-
rology 2010; 74: 702–703; author reply 703. 
 17 Fattal-Valevski A, Azouri-Fattal I, Green-
stein YJ, Guindy M, Blau A, Zelnik N: De-
layed language development due to infantile 
thiamine deficiency. Dev Med Child Neurol 
2009; 51: 629–634. 
 18 Fattal-Valevski A, Bloch-Mimouni A, Kivity 
S, et al: Epilepsy in children with infantile 
thiamine deficiency. Neurology 2009;  73: 
 828–833. 
 19 Aris B: Maker of vitamin B1-deficient baby 
milk admits error. Lancet 2003; 362: 1730. 
 20 Shamir R: Thiamine-deficient infant formu-
la: what happened and what have we learned? 
Ann Nutr Metab 2012; 60:185–187. 
 21 Dewey KG, Domellof M, Cohen RJ, Landa 
Rivera L, Hernell O, Lonnerdal B: Iron sup-
plementation affects growth and morbidity 
of breast-fed infants: results of a randomized 
trial in Sweden and Honduras. J Nutr 2002; 
 132: 3249–3255. 
 22 Domellof M: Iron requirements in infancy. 
Ann Nutr Metab 2011; 59: 59–63. 
 23 Chang H, Shi X, Shen W, Wang W, Yue Z: 
Characterization of melamine-associated 
urinary stones in children with consump-
tion of melamine-contaminated infant for-
mula. Clin Chim Acta 2012; 413: 985–991. 
 24 Panfeng S, Hong C, Zhongjin Y, et al: Manage-
ment of pediatric urolithiasis induced by 
melamine-contaminated powdered formula 
(report of 619 cases). Urology 2011; 78: 411–416. 
 25 Schoder D: Melamine milk powder and in-
fant formula sold in East Africa. J Food Prot 
2010; 73: 1709–1714. 
 26 Shang P, Chang H, Yue ZJ, et al: Acute kidney 
injury caused by consumption of melamine-
contaminated infant formula in 47 children: 
a multi-institutional experience in diagno-
sis, treatment and follow-up. Urol Res 2011, 
E-pub ahead of print. 
 27 Wei Y, Liu D: Review of melamine scandal: 
still a long way ahead. Toxicol Ind Health 
2011, E-pub ahead of print. 
 28 Gossner CM, Schlundt J, Ben Embarek P, et 
al: The melamine incident: implications for 
international food and feed safety. Environ 
Health Perspect 2009; 117: 1803–1808. 
 29 Wu MT, Wu CF, Wu JR, et al: The public 
health threat of phthalate-tainted foodstuffs 
in Taiwan: the policies the government im-
plemented and the lessons we learned. Envi-
ron Int 2012, E-pub ahead of print. 
 30 Whyatt RM, Liu X, Rauh VA, et al: Maternal 
prenatal urinary phthalate metabolite con-
centrations and child mental, psychomotor, 
and behavioral development at 3 years of age. 
Environ Health Perspect 2012; 120: 290–295. 
 31 Snijder CA, Roeleveld N, Te Velde E, et al: 
Occupational exposure to chemicals and fe-
tal growth: the Generation R Study. Hum Re-
prod 2012; 27: 910–920. 
 32 Snijder CA, Vlot IJ, Burdorf A, et al: Con-
genital heart defects and parental occupa-
tional exposure to chemicals. Hum Reprod 
2012; 27: 1510–1517. 
 33 Yen TH, Lin-Tan DT, Lin JL: Food safety in-
volving ingestion of foods and beverages pre-
pared with phthalate-plasticizer-containing 
clouding agents. J Formos Med Assoc 2011; 
 110: 671–684. 
 Koletzko et al. Ann Nutr Metab 2012;60:179–184184
 34 Cahill SM, Wachsmuth IK, Costarrica Mde 
L, Ben Embarek PK: Powdered infant formu-
la as a source of Salmonella infection in in-
fants. Clin Infect Dis 2008; 46: 268–273. 
 35 Flores JP, Medrano SA, Sanchez JS, Fernan-
dez-Escartin E: Two cases of hemorrhagic di-
arrhea caused by Cronobacter sakazakii in 
hospitalized nursing infants associated with 
the consumption of powdered infant formu-
la. J Food Prot 2011; 74: 2177–2181. 
 36 Day JB, Sharma D, Siddique N, et al: Surviv-
al of Salmonella typhi and Shigella dysente-
riae in Dehydrated Infant Formula. J Food 
Sci 2011; 76:M324–M328. 
 37 Yan QQ, Condell O, Power K, Butler F, Tall 
BD, Fanning S: Cronobacter species (former-
ly known as Enterobacter sakazakii) in pow-
dered infant formula: a review of our current 
understanding of the biology of this bacte-
rium. J Appl Microbiol 2012, E-pub ahead of 
print. 
 38 Norberg S, Stanton C, Ross RP, Hill C, 
Fitzgerald GF, Cotter PD: Cronobacter spp. 
in powdered infant formula. J Food Prot 
2012; 75: 607–620. 
 39 Jongenburger I, Reij MW, Boer EP, Gorris 
LG, Zwietering MH: Actual distribution of 
Cronobacter spp. in industrial batches of 
powdered infant formula and consequences 
for performance of sampling strategies. Int J 
Food Microbiol 2011; 151: 62–69. 
 40 Kim SA, Oh SW, Lee YM, et al: Microbial 
contamination of food products consumed 
by infants and babies in Korea. Lett Appl Mi-
crobiol 2011; 53: 532–538. 
 41 Miled RB, Guillier L, Neves S, Augustin JC, 
Colin P, Besse NG: Individual cell lag time 
distributions of Cronobacter (Enterobacter 
sakazakii) and impact of pooling samples on 
its detection in powdered infant formula. 
Food Microbiol 2011; 28: 648–655. 
 42 Agostoni C, Axelsson I, Goulet O, et al: Prep-
aration and handling of powdered infant for-
mula: a commentary by the ESPGHAN 
Committee on Nutrition. J Pediatr Gastro-
enterol Nutr 2004; 39: 320–322. 
 43 Reij MW, Jongenburger I, Gkogka E, Gorris 
LG, Zwietering MH: Perspective on the risk 
to infants in the Netherlands associated with 
Cronobacter spp. occurring in powdered in-
fant formula. Int J Food Microbiol 2009; 136: 
 232–237. 
 44 Davanzo R, Giurici N, Demarini S: Hot water 
and preparation of infant formula: how hot 
does it have to be to be safe? J Pediatr Gastro-
enterol Nutr 2010; 50: 352–353. 
 45 Turck D: Safety aspects in preparation and 
handling of infant food. Ann Nutr Metab 
2012; 60:211–214. 
 46 Guzel A, Aksu B, Aylanc H, Duran R, Karas-
alihoglu S: Scalds in pediatric emergency de-
partment: a 5-year experience. J Burn Care 
Res 2009; 30: 450–456. 
 47 Oluwafemi F, Ibeh IN: Microbial contamina-
tion of seven major weaning foods in Nige-
ria. J Health Popul Nutr 2011; 29: 415–419. 
 48 El-Tras WF, El-Kady NN, Tayel AA: Infants 
exposure to aflatoxin M as a novel foodborne 
zoonosis. Food Chem Toxicol 2011; 49: 2816–
2819. 
 49 Kvist LJ, Larsson BW, Hall-Lord ML, Steen 
A, Schalen C: The role of bacteria in lacta-
tional mastitis and some considerations of 
the use of antibiotic treatment. Int Breast-
feed J 2008; 3: 6. 
 50 Weistaub G, Uauy R: Non-breast milk feed-
ing in developing countries: challenge from 
microbial and chemical contaminants. Ann 
Nutr Metab 2012; 60:215–219. 
 51 Bonerba E, Conte R, Ceci E, Tantillo G: As-
sessment of dietary intake of patulin from 
baby foods. J Food Sci 2010; 75:T123–T125. 
 52 Khlangwiset P, Shephard GS, Wu F: Aflatox-
ins and growth impairment: a review. Crit 
Rev Toxicol 2011; 41: 740–755. 
 53 Raecker T, Thiele B, Boehme RM, Guenther 
K: Endocrine disrupting nonyl- and octyl-
phenol in infant food in Germany: consider-
able daily intake of nonylphenol for babies. 
Chemosphere 2011; 82: 1533–1540. 
 54 Fewtrell MS, Edmonds CJ, Isaacs E, Bishop 
NJ, Lucas A: Aluminium exposure from 
parenteral nutrition in preterm infants and 
later health outcomes during childhood and 
adolescence. Proc Nutr Soc 2011; 70: 299–
304. 
 55 Dabeka R, Fouquet A, Belisle S, Turcotte S: 
Lead, cadmium and aluminum in Canadian 
infant formulae, oral electrolytes and glu-
cose solutions. Food Addit Contam Part A 
Chem Anal Control Expo Risk Assess 2011; 
 28: 744–753. 
 56 Agostoni C, Axelsson I, Goulet O, et al: Soy 
protein infant formulae and follow-on for-
mulae: a commentary by the ESPGHAN 
Committee on Nutrition. J Pediatr Gastro-
enterol Nutr 2006; 42: 352–361. 
 57 Mitkus RJ, King DB, Hess MA, Forshee RA, 
Walderhaug MO: Updated aluminum phar-
macokinetics following infant exposures 
through diet and vaccination. Vaccine 2011; 
 29: 9538–9543. 
 58 Ruiz E, Santillana MI, Nieto MT, Cirugeda 
ME, Sanchez JJ: Determination of furan in 
jarred baby food purchased from the Spanish 
market by headspace gas chromatography-
mass spectrometry (HS-GC-MS). Food Ad-
dit Contam Part A Chem Anal Control Expo 
Risk Assess 2010; 27: 1208–1214. 
 59 Pavesi Arisseto A, Vicente E, De Figueiredo 
Toledo MC: Determination of furan levels in 
commercial samples of baby food from Bra-
zil and preliminary risk assessment. Food 
Addit Contam Part A Chem Anal Control 
Expo Risk Assess 2010; 27: 1051–1059. 
 60 Erkekoglu P, Baydar T: Toxicity of acryl-
amide and evaluation of its exposure in baby 
foods. Nutr Res Rev 2010; 23: 323–333. 
 61 Hilbig A, Freidank N, Kersting M, Wilhelm 
M, Wittsiepe J: Estimation of the dietary in-
take of acrylamide by German infants, chil-
dren and adolescents as calculated from di-
etary records and available data on acryl-
amide levels in food groups. Int J Hyg 
Environ Health 2004; 207: 463–471. 
 62 Hirvonen T, Jestoi M, Tapanainen H, et al: 
Dietary acrylamide exposure among Finnish 
adults and children: the potential effect of re-
duction measures. Food Addit Contam Part 
A Chem Anal Control Expo Risk Assess 
2011; 28: 1483–1491. 
 63 Birlouez-Aragon I, Morales F, Fogliano V, 
Pain JP: The health and technological impli-
cations of a better control of neoformed con-
taminants by the food industry. Pathol Biol 
(Paris) 2010; 58: 232–238. 
 64 Commission Recommendation of 2 June 
2010 on the monitoring of acrylamide levels 
in food (Text with EEA relevance) (2010/307/
EU). Official Journal L 137, 03/06/2010 P 
0004 – 0010; 2010. 
 65 Friedman M, Levin CE: Review of methods 
for the reduction of dietary content and tox-
icity of acrylamide. J Agric Food Chem 2008; 
 56: 6113–6140. 
 66 Hamrin P, Hoeft B: Quality control through-
out the production process of infant food. 
Ann Nutr Metab 2012; 60:208–210. 
 67 Simoneau C, Valzacchi S, Morkunas V, Van 
den Eede L: Comparison of migration from 
polyethersulphone and polycarbonate baby 
bottles. Food Addit Contam Part A Chem 
Anal Control Expo Risk Assess 2011; 28: 
 1763–1768. 
 68 Simoneau C, Van den Eede L, Valzacchi S: 
Identification and quantification of the mi-
gration of chemicals from plastic baby bot-
tles used as substitutes for polycarbonate. 
Food Addit Contam Part A Chem Anal Con-
trol Expo Risk Assess 2012; 29: 469–480. 
 69 Santillana MI, Ruiz E, Nieto MT, et al: Mi-
gration of bisphenol A from polycarbonate 
baby bottles purchased in the Spanish mar-
ket by liquid chromatography and fluores-
cence detection. Food Addit Contam Part A 
Chem Anal Control Expo Risk Assess 2011; 
 28: 1610–1618. 
 70 Fewtrell MS: Clinical safety assessment of 
infant nutrition. Ann Nutr Metab 2012; 
 60:200–203. 
 71 Lönnerdal B: Preclinical assessment of in-
fant formula. Ann Nutr Metab 2012; 60:196–
199. 
 72 Szajewska H: The role of systematic data re-
views in safety assessment of infant nutri-
tion. Ann Nutr Metab 2012; 60:204–207. 
 73 Welch RW, Antoine JM, Berta JL, et al: 
Guidelines for the design, conduct and re-
porting of human intervention studies to 
evaluate the health benefits of foods. Br J 
Nutr 2011; 106(suppl 2):S3–S15. 
 74 Bier DM: Safety standards in infant nutri-
tion: a United States perspective. Ann Nutr 
Metab 2012; 60:192–195. 
 75 Hernell O: Current safety standards in infant 
nutrition – a European perspective. Ann 
Nutr Metab 2012; 60:188–191. 
 
Erratum 
In the article by Koletzko et al.: Quality and Safety Aspects of Infant Nutrition. Ann Nutr 
Metab 2012;60:179–184 (DOI:10.1159/000338803), the last sentence in the Acknowledge-
ment has to read:
We thank Abbott Nutrition, Danone Research, Dairy Goat Cooperative, DSM Nutri-
tional Products, Hipp GmbH, Mead Johnson Nutritionals and United Pharmaceuticals 
for additional support through unrestricted educational grants.
